You're reading the free version. Trader adds the live tape and alerts.
Start tracking
UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Nov 6, 2026
Sale
Calculated transaction value
$334.43K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Nov 5, 2026
Public filing date
Nov 6, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$565.72
Nov 5, 2026
First close after public filing
$582.46
Nov 9, 2026
Return after filing · so far
+2.27%
Through Nov 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 585 shares @ $571.67
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000181
Filing cohort
Transactions in this filing
Showing 15 of 26
Trades
26
Issuers
1
Estimated value
$5.45M
Buys / sales
0 / 24
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Sale | Nov 5, 2026 | $320.64K |
| United Therapeutics Corp UTHR | Sale | Nov 5, 2026 | $92.71K |
| United Therapeutics Corp UTHR | Sale | Nov 5, 2026 | $159.28K |
| United Therapeutics Corp UTHR | Sale | Nov 5, 2026 | $214.73K |
| United Therapeutics Corp UTHR | Sale | Nov 5, 2026 | $47.18K |
| United Therapeutics Corp UTHR | Sale | Nov 5, 2026 | $94.65K |
| United Therapeutics Corp UTHR | Exercise | Nov 5, 2026 | $0 |
| United Therapeutics Corp UTHR | Exercise | Nov 5, 2026 | $1.12M |
| United Therapeutics Corp UTHR | Sale | Nov 5, 2026 | $180K |
| United Therapeutics Corp UTHR | Sale | Nov 5, 2026 | $310.99K |
| United Therapeutics Corp UTHR Current | Sale | Nov 5, 2026 | $334.43K |
| United Therapeutics Corp UTHR | Sale | Nov 5, 2026 | $293.27K |
| United Therapeutics Corp UTHR | Sale | Nov 5, 2026 | $407.03K |
| United Therapeutics Corp UTHR | Sale | Nov 5, 2026 | $261.77K |
| United Therapeutics Corp UTHR | Sale | Nov 5, 2026 | $88.6K |